186 related articles for article (PubMed ID: 33420235)
1. Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients.
Miller BF; Petrykowska HM; Elnitski L
Sci Rep; 2021 Jan; 11(1):221. PubMed ID: 33420235
[TBL] [Abstract][Full Text] [Related]
2. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.
Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L
Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832
[TBL] [Abstract][Full Text] [Related]
3. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.
Sánchez-Vega F; Gotea V; Petrykowska HM; Margolin G; Krivak TC; DeLoia JA; Bell DW; Elnitski L
Epigenetics; 2013 Dec; 8(12):1355-72. PubMed ID: 24149212
[TBL] [Abstract][Full Text] [Related]
4. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
5. Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.
Margolin G; Petrykowska HM; Jameel N; Bell DW; Young AC; Elnitski L
J Mol Diagn; 2016 Mar; 18(2):283-98. PubMed ID: 26857064
[TBL] [Abstract][Full Text] [Related]
6. Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer.
Wiesmueller F; Kopke J; Aust D; Roy J; Dahl A; Pilarsky C; Grützmann R
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683647
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation marker to estimate ovarian cancer cell fraction.
Ebata T; Yamashita S; Takeshima H; Yoshida H; Kawata Y; Kino N; Yasugi T; Terao Y; Yonemori K; Kato T; Ushijima T
Med Oncol; 2022 Feb; 39(5):78. PubMed ID: 35195779
[TBL] [Abstract][Full Text] [Related]
8. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
[TBL] [Abstract][Full Text] [Related]
9. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
[TBL] [Abstract][Full Text] [Related]
10. Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.
Wu HC; Yang HI; Wang Q; Chen CJ; Santella RM
Carcinogenesis; 2017 Oct; 38(10):1021-1028. PubMed ID: 28981677
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial.
Herzog C; Jones A; Evans I; Reisel D; Olaitan A; Doufekas K; MacDonald N; Rådestad AF; Gemzell-Danielsson K; Zikan M; Cibula D; Dostálek L; Paprotka T; Leimbach A; Schmitt M; Ryan A; Gentry-Maharaj A; Apostolidou S; Rosenthal AN; Menon U; Widschwendter M
Int J Cancer; 2024 Feb; 154(4):679-691. PubMed ID: 37861205
[TBL] [Abstract][Full Text] [Related]
12. Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy.
Jin S; Zhu D; Shao F; Chen S; Guo Y; Li K; Wang Y; Ding R; Gao L; Ma W; Lu T; Li D; Zhang Z; Cai S; Liang X; Song H; Ji L; Li J; Zheng Z; Jiang F; Wu X; Luan J; Zhang H; Yang Z; Cantor CR; Xu C; Ding C
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495330
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.
Reinert T; Borre M; Christiansen A; Hermann GG; Ørntoft TF; Dyrskjøt L
PLoS One; 2012; 7(10):e46297. PubMed ID: 23056278
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.
Li L; Zheng H; Huang Y; Huang C; Zhang S; Tian J; Li P; Sood AK; Zhang W; Chen K
Carcinogenesis; 2017 Aug; 38(8):797-805. PubMed ID: 28637314
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers.
Koestler DC; Marsit CJ; Christensen BC; Accomando W; Langevin SM; Houseman EA; Nelson HH; Karagas MR; Wiencke JK; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1293-302. PubMed ID: 22714737
[TBL] [Abstract][Full Text] [Related]
16. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
17. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?
Gall TM; Frampton AE; Krell J; Habib NA; Castellano L; Stebbing J; Jiao LR
Future Oncol; 2013 Dec; 9(12):1861-9. PubMed ID: 24295416
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
